AstraZeneca PLC's Fiscal Year is From January To December.
The item "Cash-Ratio" stands at 0.2403 as of 09/30/2025, the highest value since 09/30/2024.
As of the end of AstraZeneca PLC's third quarter, the item "Cash Ratio" stands at 0.2403. This represents an increase of 13.27 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 26.64 percent compared to the value the year prior.
The 1 year change in percent is 26.64.
The 3 year change in percent is 22.99.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash Ratio | 317,433,206,677.55 |
![]() | Novartis AG - Cash Ratio | 255,096,620,580.91 |